There is evidence from preclinical studies that increased FKBP5 expression in specific brain regions is associated with risk-promoting sleep architecture and with increased stress responsiveness and anxiety [12,13,14,15], all of which are associated with increased vulnerability to psychiatric disorders. The gene discussed is FKBP5; the disease is psychiatric disorder.